Emcure Pharmaceuticals consolidated net profit rises 49.97% in the December 2025 quarter
(04 Feb 2026)

Back
Net profit of Emcure Pharmaceuticals rose 49.97% to Rs 230.54 crore in the quarter ended December 2025 as against Rs 153.72 crore during the previous quarter ended December 2024. Sales rose 20.42% to Rs 2363.48 crore in the quarter ended December 2025 as against Rs 1962.63 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales2363.481962.63 20
OPM %20.8518.07 -
PBDT456.62326.73 40
PBT351.94229.92 53
NP230.54153.72 50

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew